Localization of the Complement C1q-Binding Site on Echinococcus multilocularis Calreticulin Identified by Peptide...

Area of Science:

• Parasitology
• Immunology
• Biochemistry

Background:

• Alveolar echinococcosis is a severe zoonotic disease caused by Echinococcus multilocularis.
• E. multilocularis larvae evade host immunity using immunomodulatory proteins.
• E. multilocularis calreticulin (EmCRT) inhibits complement activation by binding C1q.

Purpose of the Study:

• To pinpoint the exact C1q-binding site on EmCRT.
• To understand how EmCRT mediates C1q inactivation and immune evasion.

Main Methods:

• Expression of overlapping EmCRT fragments and synthesis of overlapping peptides.
• Functional assays to assess C1q binding and complement inhibition.
• Analysis of C1q-mediated neutrophil responses.

Main Results:

• The C1q-binding site was localized to the EmCRT-S1 fragment (amino acids 140-204).
• The P5 peptide (EmCRT160-174 aa) was identified as the precise binding site.
• P5 peptide binding to C1q suppressed classical complement pathway activation and neutrophil functions.

Conclusions:

• The P5 peptide of EmCRT is crucial for C1q inactivation and immune evasion.
• This peptide represents a potential therapeutic target for echinococcosis vaccines.
• The P5 peptide could be explored for treating complement-mediated inflammatory and autoimmune diseases.